Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

By A. Kastrati, J. Mehilli, J. Pache, C. Kaiser, M. Valgimigli, H. Kelbaek, M. Menichelli, M. Sabaté, M. Suttorp, D. Baumgart and 3 more. New England Journal of Medicine, 2007

1,086 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/d307bac32b4a4b2aef8b0fde53ec234f5f4cef87

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Rick A. Nishimura
2. C. Yancy

Citations in the corpus

• Application of Light Scattering Techniques to Nanoparticle Characterization and Development (2018, background): “has a risk for thrombosis at least as great as with bare-metal stents, showing no significant effect in long-term survival and a reduction in the need for re-intervention (Kastrati et al., 2007).”
• Coronary stents: current status. (2010, positive): “001), with DES performing much better han BMS (26).”
• ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007, background): “Kastrati et al (345) reported that 4958 patients randomized to DES or bare-metal stents and followed up for 12 to 59 months had no significant difference in the incidence of death or MI, but there was a sustained reduction in the need for reintervention with DES.”